PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 220.00
Bid: 218.50
Ask: 219.50
Change: -2.00 (-0.90%)
Spread: 1.00 (0.458%)
Open: 218.50
High: 224.50
Low: 217.00
Prev. Close: 222.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output up

Wed, 10th Nov 2021 18:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Permanent TSB Group Holdings PLC - Dublin-based personal and small business bank - Sells loan portfolio to Morgan Stanley Principal Funding Inc. Portfolio had gross balance sheet value of EUR390 million. Notes 98% of loans categorised as non-performing. "The remaining 2% comprise loan products which originated pre 2009 and which are no longer available to new customers. Typically these are interest only or part capital & interest loans where the borrower and the bank have failed to agree a plan which will ensure the repayment of the outstanding balance (often the original amount which was borrowed) at the end of the agreed loan term," company adds.

----------

Dekel Agri-Vision PLC - West Africa-focused agriculture company - Crude palm oil output rises 28% year-on-year in October to 2,331 tonnes. Sales improve 25% to 2,301 tonnes. Price per CPO tonne up 51% EUR960 from EUR636 a year earlier. "A year of strong production and even stronger prices continues to set Dekel up for a record year of financial performance in our palm oil operation in 2021. Given current prices remain materially higher than we achieved in this year's high season earlier in the year we remain optimistic of a further uplift in the financial performance of the palm oil operation in 2022," says Executive Director Lincoln Moore.

----------

Power Metal Resources PLC - exploration company seeking metal discoveries in the US, Australia and Africa - Expands uranium exploration portfolio at Athabasca basin in Canada. Land holdings increase by 144.84 square kilometres to a total of 411.96 square kilometres. "The additional areas staked by the company are prospective for uranium and base-metals," Chief Executive Officer Paul Johnson says.

----------

Pembridge Resources PLC - London-based investor in Minto Explorations Ltd - Says TSX Venture Exchange conditionally accepts reverse takeover of 1246778 BC Ltd by Minto Explorations. "This conditional acceptance by TSXV clears an important hurdle in Minto's path to being a listed company and we appreciate the work that has been done by Minto and its advisors on the RTO and listing process," Pembridge Chair & Chief Executive Gati Al-Jebouri says.

----------

Kefi Gold & Copper PLC - gold explorer in Ethiopia and Saudi Arabia - Says final assay results received for phase 4 drilling campaign at Hawiah copper and gold project in Saudi Arabia. An updated mineral resource estimate is expected in December. "The updated MRE is expected to include the additional resources previously defined in the phase 3 drilling programme, as well as material in the indicated category where in-fill drilling has taken place," Kefi says. Phase 4 assays signal "overall increase in the resource grades for copper, zinc, gold, and silver", company adds.

----------

PureTech Health PLC - Massachusetts, US-based biotechnology company - Sells 750,000 shares in founded entity Karuna Therapeutics, pocketing USD100 million. "PureTech intends to use the proceeds from the Transaction to further the advancement and growth of the company and will update its cash runway guidance in due course," PureTech says. Now has 5.6% Karuna stake.

----------

Image Scan Holdings PLC - Leicestershire, England-based X-ray imaging systems provider - Awarded contract to supply a portable X-ray scanning system to a US federal agency. "The contract is the first part of a framework order that could lead to the purchase of a further twelve systems," Image Scan says. In addition, company named global distributor for Serstech AB, a technology company working in the field of chemical analysis in Sweden. Company says: "Under the agreement, Image Scan will market Serstech's range of highly portable chemical analysers to bomb squads, hazardous material investigation teams and customs organisations through its global distribution network. In different scenarios, the technology is used to identify explosives, explosive precursors, chemical spills, and illegal drugs."

----------

Enteq Technologies PLC - Buckinghamshire-based oil and gas services provider - Signs two exclusive distribution agreements with third-party technology providers. These "enhance and complement Enteq's product range". One deal has been struck with Texas-based Erdos Miller Inc. It will be "exclusive distributor outside North America for two of their major product lines". In addition, strikes deal with Alberta, Canada-based Mezintel Inc "for their gamma logging and depth tracking software solutions".

----------

Evgen Pharma PLC - Liverpool-based sulforaphane based medical drug developer - Notes data on preclinical models of glioblastoma published at universities of Aquila, Rome and Rieti in Italy. Glioblastoma, or GBM, is an aggressive type of cancer. Data finds anti-tumour activity by Evgen's SFX-01 asset. "The in vitro data, in GBM cells and patient-derived glioma-initiating cells, show anti-tumour activity of the company's lead asset SFX-01. The work goes on to show in vivo anti-tumour activity in both sub-cutaneous and orthotopic xenograft (tumour cell lines are implanted in the brain) models of GBM," Evgen says.

----------

Insig AI PLC - London-based machine learning and data science firm serving asset management industry, formerly known as Catena - Delivers environmental, social and corporate governance scoring platform to alternative investment manager CarVal Investors LP. Notes CarVal's ESG risk assessment model includes carbon emissions, health and safety labour management, board composition and raw material sourcing.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
5 Sep 2022 11:40

IN BRIEF: PureTech Health data on fibrosis drug candidate positive

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Posts positive data from a phase 1 trial of its idiopathic pulmonary fibrosis drug candidate LYT-100, or deupirfenidone.

Read more
31 Aug 2022 20:31

TOP NEWS: ConvaTec to join FTSE 100 as abrdn vacates spot

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 19 after completing its quarterly review.

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 11:03

SMALL-CAP WINNERS & LOSERS: Hunting surges as loss narrows, ups payout

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

Read more
25 Aug 2022 10:10

IN BRIEF: PureTech Health loss narrows in "exceedingly strong" half

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Pretax loss in the first half 2022 narrows to USD56.0 million from USD94.9 million a year before. This is due to a USD28.4 million gain on the dilution of its equity interest in Gelesis Inc. Revenue grows 21% to USD7.0 million from USD5.8 million. Attributes this to increased grant revenue from the Vedanta CARB-X and BARDA grant, as well as Alivio and PureTech LYT Inc.

Read more
25 Aug 2022 09:25

PureTech first-half mixed as it makes good clinical progress

(Sharecast News) - PureTech Health reported total first-half revenue of $7.03m on Thursday, up from $5.84m year-on-year.

Read more
24 Aug 2022 17:58

IN BRIEF: PureTech Health's Sonde Health signs deal for COPD in India

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says its founded entity, Sonde Health, has signed a multi-year agreement with specialty pharmaceutical company Koye Pharmaceuticals Pvt Ltd. The agreement is to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This is Sonde's first partnership with a pharmaceutical firm, PureTech adds.

Read more
23 Aug 2022 18:14

TOP NEWS: abrdn indicated to drop out of FTSE 100, F&C to join

(Alliance News) - Almost 18 months after announcing a name change, abrdn PLC's blue-chip status is under threat, according to indicative index changes provided by FTSE Russell on Tuesday.

Read more
22 Aug 2022 09:15

PureTech Health's Akili raises USD163 million via Nasdaq IPO

(Alliance News) - PureTech Health PLC said founded entity Akili Inc will start trading on the Nasdaq Capital Market on Monday, after raising funds which will go towards video-game based treatment for children.

Read more
9 Aug 2022 09:31

PureTech gets USD115 million from sale of Karuna Therapeutics shares

(Alliance News) - PureTech Health PLC on Tuesday announced it received USD115.4 million after selling a portion of its stake in Karuna Therapeutics Inc.

Read more
8 Aug 2022 17:06

LONDON MARKET CLOSE: Strong start to week as US inflation data looms

(Alliance News) - Stocks in London sprang into the new week after Friday's US jobs data lessened recession fears.

Read more
8 Aug 2022 16:21

IN BRIEF: PureTech shares jump on Karuna Therapeutics trial results

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says founded entity Karuna Therapeutics reports positive phase III trial results from Emergent-2 trial for KarXT in schizophrenia. KarXT, or xanomeline-trospium, met its primary endpoint in the trial, showing a significant 9.6 point reduction in Positive and Negative Syndrome Scale total score compared to a placebo. The PANSS scale measures the symptom severity of patients with schizophrenia. The trial also met key secondary endpoints, the firm says. Karuna plans to submit a new drug application with the US Food & Drug Administration in mid-2023.

Read more
1 Aug 2022 21:21

IN BRIEF: PureTech Health's Aliki starts phase three study for SDT-001

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Notes that founded entity Akili Interactive Labs Inc has start a pivotal phase three randomised, controlled study of SDT-001, a candidate designed to improve the measures of attention in children diagnosed with ADHD.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.